These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 19127251)
1. Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases. Joo KM; Park IH; Shin JY; Jin J; Kang BG; Kim MH; Lee SJ; Jo MY; Kim SU; Nam DH Mol Ther; 2009 Mar; 17(3):570-5. PubMed ID: 19127251 [TBL] [Abstract][Full Text] [Related]
2. Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors. Kang W; Seol HJ; Seong DH; Kim J; Kim Y; Kim SU; Nam DH; Joo KM Oncol Rep; 2013 Sep; 30(3):1101-6. PubMed ID: 23828015 [TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties. Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744 [TBL] [Abstract][Full Text] [Related]
4. Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models. Yi BR; Hwang KA; Aboody KS; Jeung EB; Kim SU; Choi KC Stem Cell Res; 2014 Jan; 12(1):36-48. PubMed ID: 24141111 [TBL] [Abstract][Full Text] [Related]
5. Neural stem cell-based dual suicide gene delivery for metastatic brain tumors. Wang C; Natsume A; Lee HJ; Motomura K; Nishimira Y; Ohno M; Ito M; Kinjo S; Momota H; Iwami K; Ohka F; Wakabayashi T; Kim SU Cancer Gene Ther; 2012 Nov; 19(11):796-801. PubMed ID: 23018623 [TBL] [Abstract][Full Text] [Related]
6. Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node-Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models. Park GT; Kim SU; Choi KC Cancer Res Treat; 2017 Jan; 49(1):79-91. PubMed ID: 27188205 [TBL] [Abstract][Full Text] [Related]
7. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models. Kang NH; Hwang KA; Yi BR; Lee HJ; Jeung EB; Kim SU; Choi KC Cancer Gene Ther; 2012 Jun; 19(6):412-9. PubMed ID: 22498724 [TBL] [Abstract][Full Text] [Related]
8. Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models. Yi BR; Park MA; Lee HR; Kang NH; Choi KJ; Kim SU; Choi KC Mol Oncol; 2013 Jun; 7(3):543-54. PubMed ID: 23403306 [TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of therapeutic stem cells expressing cytosine deaminase and interferon-beta via apoptotic pathway in the metastatic mouse model of breast cancer. Yi BR; Kim SU; Choi KC Oncotarget; 2016 Feb; 7(5):5985-99. PubMed ID: 26716512 [TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells. Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic tumor mass in a xenograft mouse model is decreased by treatment with therapeutic stem cells following introduction of therapeutic genes. Kim DJ; Yi BR; Lee HR; Kim SU; Choi KC Oncol Rep; 2013 Sep; 30(3):1129-36. PubMed ID: 23807450 [TBL] [Abstract][Full Text] [Related]
12. Antithyroid cancer effects of human neural stem cells expressing therapeutic genes on anaplastic thyroid cancer cells. Shin HJ; Hwang KA; Go RE; Kim SU; Choi KC J Cell Biochem; 2020 Feb; 121(2):1586-1598. PubMed ID: 31512776 [TBL] [Abstract][Full Text] [Related]
13. The growth of K562 human leukemia cells was inhibited by therapeutic neural stem cells in cellular and xenograft mouse models. Park GT; Heo JR; Kim SU; Choi KC Cytotherapy; 2018 Sep; 20(9):1191-1201. PubMed ID: 30078654 [TBL] [Abstract][Full Text] [Related]
14. Effects of genetically engineered stem cells expressing cytosine deaminase and interferon-beta or carboxyl esterase on the growth of LNCaP rrostate cancer cells. Yi BR; Hwang KA; Kim YB; Kim SU; Choi KC Int J Mol Sci; 2012 Sep; 13(10):12519-32. PubMed ID: 23202910 [TBL] [Abstract][Full Text] [Related]
15. Additional effects of engineered stem cells expressing a therapeutic gene and interferon-β in a xenograft mouse model of endometrial cancer. Yi BR; Kim SU; Choi KC Int J Oncol; 2015 Jul; 47(1):171-8. PubMed ID: 25963746 [TBL] [Abstract][Full Text] [Related]
16. Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer. Seol HJ; Jin J; Seong DH; Joo KM; Kang W; Yang H; Kim J; Shin CS; Kim Y; Kim KH; Kong DS; Lee JI; Aboody KS; Lee HJ; Kim SU; Nam DH Cancer Lett; 2011 Dec; 311(2):152-9. PubMed ID: 21868150 [TBL] [Abstract][Full Text] [Related]
17. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model. You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256 [TBL] [Abstract][Full Text] [Related]
18. Selective delivery of a therapeutic gene for treatment of head and neck squamous cell carcinoma using human neural stem cells. Kwon SK; Kim SU; Song JJ; Cho CG; Park SW Clin Exp Otorhinolaryngol; 2013 Sep; 6(3):176-83. PubMed ID: 24069522 [TBL] [Abstract][Full Text] [Related]
19. Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response. Lee SJ; Kim Y; Jo MY; Kim HS; Jin Y; Kim SU; Jin J; Joo KM; Nam DH Oncol Rep; 2011 Jan; 25(1):63-8. PubMed ID: 21109958 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of genetically modified human neural stem cells encoding cytosine deaminase on experimental glioma. Kim JH; Kim JY; Kim SU; Cho KG Biochem Biophys Res Commun; 2012 Jan; 417(1):534-40. PubMed ID: 22177952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]